(Circulation. 2000;101:1867.)
© 2000 American Heart Association, Inc.
Basic Science Reports |
From the Department of Surgery (S.S., R.A.H.) and Departments of Pediatrics and Immunology (C.P.P., J.L.P.), Mayo Clinic, Rochester, Minn.
Correspondence to Soheyla Saadi, PhD, Mayo Clinic, Medical Science 266, Rochester, MN 55905. E-mail saadi.soheyla{at}mayo.edu
BackgroundInteraction of
complement with endothelial cells (ECs) underlies the
development of inflammation and coagulation in disease. Assembly of the
membrane attack complex (MAC) of complement on EC membrane, like
stimulation with cytokines, upregulates tissue factor and
cyclooxygenase-2 but does so via the intermediary
action of IL-1
. We asked whether the MAC activates porcine
aortic and microvascular ECs in a global manner by this mechanism and
whether this mechanism is used by membrane pore-forming
structures.
Methods and ResultsExposure of ECs to complement caused
upregulation of mRNAs for E-selectin, intracellular adhesion
molecule-1, vascular cell adhesion molecule-1, I
-B
, interleukin
(IL)-1
, IL-1ß, IL-8, and plasminogen
activator inhibitor-1 over a period of 6 hours.
The expression of these genes was not a primary response to
stimulation, however, because IL-1 receptor antagonist
inhibited expression of these genes. Activation of ECs by complement
depended on the autocrine action of IL-1
, because
complement-mediated EC activation was inhibited by antiIL-1
antibodies. Melittin and mastoparan, amphiphilic pore-forming peptides
like the MAC, induced E-selectin through intermediary action of
IL-1.
ConclusionsThese findings suggest that transmembrane
pore-forming proteins, as a class of molecules, activate ECs
through the autocrine effects of IL-1
.
Key Words: pore-forming peptides endothelium interleukin-1
This article has been cited by other articles:
![]() |
L. R. La Bonte, B. Dokken, G. Davis-Gorman, G. L. Stahl, and P. F. McDonagh The mannose-binding lectin pathway is a significant contributor to reperfusion injury in the type 2 diabetic heart Diabetes and Vascular Disease Research, July 1, 2009; 6(3): 172 - 180. [Abstract] [PDF] |
||||
![]() |
G Girardi and N Mackman Tissue factor in antiphospholipid antibody-induced pregnancy loss: a pro-inflammatory molecule Lupus, October 1, 2008; 17(10): 931 - 936. [Abstract] [PDF] |
||||
![]() |
G. J. Brunn, S. Saadi, and J. L. Platt Constitutive Repression of Interleukin-1{alpha} in Endothelial Cells Circ. Res., April 11, 2008; 102(7): 823 - 830. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. La Bonte, G. Davis-Gorman, G. L. Stahl, and P. F. McDonagh Complement inhibition reduces injury in the type 2 diabetic heart following ischemia and reperfusion Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1282 - H1290. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Rao, K. J. Tracey, and J. S. Pober IL-1{alpha} and IL-1beta Are Endogenous Mediators Linking Cell Injury to the Adaptive Alloimmune Response J. Immunol., November 15, 2007; 179(10): 6536 - 6546. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Redecha, R. Tilley, M. Tencati, J. E. Salmon, D. Kirchhofer, N. Mackman, and G. Girardi Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury Blood, October 1, 2007; 110(7): 2423 - 2431. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Simeoni, J. Dudler, S. Fleury, J. Li, M. Pagnotta, M. Pascual, L. K. von Segesser, and G. Vassalli Gene transfer of a soluble IL-1 type 2 receptor-Ig fusion protein improves cardiac allograft survival in rats Eur. J. Cardiothorac. Surg., February 1, 2007; 31(2): 222 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Tinckam and A. Chandraker Mechanisms and Role of HLA and non-HLA Alloantibodies Clin. J. Am. Soc. Nephrol., May 1, 2006; 1(3): 404 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Brunn, S. Saadi, and J. L. Platt Differential Regulation of Endothelial Cell Activation by Complement and Interleukin 1{alpha} Circ. Res., March 31, 2006; 98(6): 793 - 800. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Koch, A. Kanazawa, R. Nishitai, B. E. Knudsen, K. Ogata, T. B. Plummer, K. Butters, and J. L. Platt Intrinsic Resistance of Hepatocytes to Complement-Mediated Injury J. Immunol., June 1, 2005; 174(11): 7302 - 7309. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Turnberg, M. Botto, M. Lewis, W. Zhou, S. H. Sacks, B. P. Morgan, M. J. Walport, and H. T. Cook CD59a Deficiency Exacerbates Ischemia-Reperfusion Injury in Mice Am. J. Pathol., September 1, 2004; 165(3): 825 - 832. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Koch, Z. I. Khalpey, and J. L. Platt Accommodation: Preventing Injury in Transplantation and Disease J. Immunol., May 1, 2004; 172(9): 5143 - 5148. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Saadi, T. Takahashi, R. A. Holzknecht, and J. L. Platt Pathways to Acute Humoral Rejection Am. J. Pathol., March 1, 2004; 164(3): 1073 - 1080. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Turnberg, M. Botto, J. Warren, B. P. Morgan, Mark. J. Walport, and H. T. Cook CD59a Deficiency Exacerbates Accelerated Nephrotoxic Nephritis in Mice J. Am. Soc. Nephrol., September 1, 2003; 14(9): 2271 - 2279. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. SAADI, L. E. WRENSHALL, and J. L. PLATT Regional manifestations and control of the immune system FASEB J, June 1, 2002; 16(8): 849 - 856. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Jordan, M. C. Montalto, and G. L. Stahl Inhibition of Mannose-Binding Lectin Reduces Postischemic Myocardial Reperfusion Injury Circulation, September 18, 2001; 104(12): 1413 - 1418. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |